Test will help match patients with blood cancer to right treatments

05/3/2013 | Boston Globe (tiered subscription model), The

Foundation Medicine has entered a collaboration with Memorial Sloan-Kettering Cancer Center for the development of a test to help identify the best hematologic cancer treatments for individual patients. The test will employ RNA and DNA sequencing to classify hematologic conditions.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ